Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Truist Securities Initiates Coverage On Cyclerion Therapeutics with Buy Rating, Announces Price Target of $14


Benzinga | Oct 20, 2021 07:04AM EDT

Truist Securities Initiates Coverage On Cyclerion Therapeutics with Buy Rating, Announces Price Target of $14

Truist Securities initiates coverage on Cyclerion Therapeutics (NASDAQ:CYCN) with a Buy rating and announces Price Target of $14.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC